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In bacterialmeningitis, chemokines lead to recruitment of polymorphonuclear leucocytes (PMN) into theCNS.
At the site of infection in the subarachnoid space, PMN release reactive oxygen species, reactive nitrogen
intermediates (RNI) and interleukin-1b (IL-1b). Although these immune factors assist in clearance of bacteria,
they also result in neuronal injury associated with meningitis. Transforming growth factor beta (TGFb) is a
potent deactivator of PMNandmacrophages since TGFb suppresses the production of ROI, RNI and IL-1. Here,
we report that the deletion of the TGFb receptor II gene in PMN enhances PMN recruitment into the CNS of
mice with Streptococcus pneumoniaemeningitis. This was associated with more efficient clearance of bacteria,
and almost complete prevention of intracerebral necrotizing vasculitis. Differences in PMN in the CNS of
infected control mice and mice lacking TGFb receptor II were not explained by altered expression of chemo-
kines acting on PMN. Instead, TGFb was found to impair the expression of L (leucocyte)-selectin on PMN from
control mice but not from mice lacking TGFb receptor II. L-Selectin is known to be essential for PMN recruit-
ment in bacterial meningitis. We conclude that defective TGFb signalling in PMN is beneficial in bacterial
meningitis by ameliorating migration of PMN and bacterial clearance.
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Introduction
Polymorphonuclear leucocytes (PMN) and macrophages
have the capacity to phagocytose and kill bacteria. Binding
of bacteria to pattern recognition receptors of the Toll-like
receptor (TLRs) family on phagocytes leads to an inflamma-
tory response. TLR2 and TLR4 recognize pneumococcal
cell wall components and the pneumococcal cytotoxin pneu-
molysin, respectively (Yoshimura et al., 1999; Malley et al.,
2003; Schroder et al., 2003) In cooperation with other TLRs,
such as TLR1 (Schmeck et al., 2006) downstream events—
involving the MyD-88 adaptor protein, phosphorylation of
interleukin receptor-associated kinase (IRAK), activation of
tumour necrosis factor receptor-activated factor 6 (TRAF6),
activating protein 1 (AP-1) and nuclear translocation of
nuclear factor kB (NF-kB)—lead to the production of
inflammatory cytokines and chemokines, including
interleukin-1b (IL-1b) and tumour necrosis factor-a
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(TNF-a) (for review, see Barton and Medzhitov, 2003; Akira
et al., 2006). In pneumococcal meningitis, these cytokines
together with reactive oxygen species, reactive nitrogen inter-
mediates (RNI) and matrix metalloproteinases (MMP) con-
tribute to the disruption of the blood–brain barrier (BBB),
and thereby enable leucocytes to be recruited to the site of
infection. Recruitment of PMN into the CNS depends on the
expression of selectins and b2 integrins on both endothelial
cells and PMN as well as on chemokines, particularly macro-
phage inflammatory protein-2 (MIP-2/CXCL2) and KC/
Groa (CXCL1) (for review, see Koedel et al., 2002; Meli
et al., 2002). Owing to low concentrations of antibacterial
antibodies and complement factors in the CNS, the elimina-
tion of bacteria at this site of the body is not efficient
(Zwahlen et al., 1982). As a consequence, phagocytes are
continuously stimulated, secrete inflammatory mediators
and cause CNS damage. Disruption of the BBB leads to
brain oedema formation and increased intracranial pressure
(ICP) with impaired cerebral blood flow. These changes ulti-
mately cause irreversible neuronal injury (for review, see
Koedel et al., 2002; Nau and Bruck, 2002; Kim, 2003)
The delicate balance between leucocyte activation to cope
with bacteria and leucocyte deactivation to prevent their
harmful potential to cause tissue injury may be guided by
transforming growth factor beta (TGFb). There are three
members of the TGFb family—TGFb1, TGFb2, and
TGFb3—which share a high degree of homology both at
the structural and functional level. In the CNS, TGFb1 expre-
ssion is largely confined to the meninges and choroid plexus,
whereas TGFb2 and TGFb3 are expressed in neurons and
glial cells (Flanders et al., 1991). They exert their effects
through a heteromeric receptor complex consisting of type
I and type II transmembrane serine/threonine kinase recep-
tors. Upon ligand binding the type II receptor (TGFbRII)
transphosphorylates and activates the type I receptor, which
catalyses receptor-regulated SMAD transcription factor phos-
phorylation, and thereby in cooperation with co-SMADs
enables TGFb signalling (Massague, 1996; Yang et al.,
2003). On peripheral blood monocytes TGFb is chemotactic,
enhances phagocytosis, activates the production of
cytokines—IL-1, TNFa—and leads to increased expression
of several integrin receptors including LFA-1, VLA-3 and
VLA-5 (for review, see Letterio and Roberts, 1998). However,
when testing TGFb on tissue macrophages including micro-
glia, the cytokine was found to inhibit phagocytosis as well
as the production of TNFa, IL-1, IL-6, ROI, and to induce
increased expression of IL-1 receptor antagonist (Tsunawaki
et al., 1988; Turner et al., 1991; Suzumura et al., 1993; Kim
et al., 2004).
The discrepancy between the macrophage activating and
deactivating properties of TGFb is also true for PMN. TGFb
exerts strong chemotactic responses on PMN in vitro and,
upon intraarticular injection, induces synovial inflammation
in mice (Wahl et al., 1987; Allen et al., 1990; Welch et al.,
1990; Reibman et al., 1991). However, TGFb was found
to inhibit extravasation of PMN in thioglycollate-induced
peritonitis (Gresham et al., 1991). Experiments on the role
of TGFb in bacterial infections have resulted in conflicting
results. In a murine model of autoimmunity, MRL/lpr mice
have been reported to express constitutively high levels of
TGFb. Intravenous injections of anti-TGFb antibodies
improved the survival of MRL/lpr mice when infected intra-
peritoneally with Staphylococcus aureus or Escherichia coli;
this effect of anti-TGFb antibodies was associated with
enhanced PMN extravasation to the site of infection
(Lowrance et al., 1994). The data obtained in autoimmune
MRL/lpr mice are in contrast with the ability of TGFb to
induce leucocyte recruitment and to improve microbial
clearance when administered via intrabronchial routes to
rats with E. coli pneumoniae (Cui et al., 2003). In early
pneumococcal meningitis in rats, the effect of TGFb on
inflammation was dependent on the route of administration.
The local, intracisternal administration of TGFb was found to
drive the inflammatory response (Koedel et al., 1996),
whereas intraperitoneal application of TGFb inhibited the
same response (Pfister et al., 1992). Neither the role of
endogenous TGFb nor the role of TGFb in more advanced
meningitis models has been investigated so far. To address
whether the endogenous production of TGFb during
bacterial infections affects the function of phagocytes, we
have generated mice that lack TGFb receptor II expression
on PMN and macrophages (phag-TGFbRII/ mice).
Material and methods
Generation of phag-TGFbRII/ mice
TGFbRIIflox/flox mice were obtained from Stefan Karlsson and Per
Leve´en, Lund University, Sweden (Leveen et al., 2002), and LysM-cre
mice were generously provided by Irmgard Fo¨rster, University of
Du¨sseldorf, Germany (Clausen et al., 1999). The TGFbRIIflox/flox
mice were crossed with LysM-cre to yield a homozygous
TGFbRIIflox/flox background and heterozygous background for
LysM-cre. Cre non-expressing littermates were used as controls.
The genotype of the offspring was determined by polymerase
chain reaction (PCR) using the primer pair P3/P4 (P3: 50-
tatggactggctgcttttgtattc-30 and P4: 50-tggggatagaggtagaaagacata-30)
to distinguish floxed alleles (575 bp) from wild-type (422 bp)
(Leveen et al., 2002). The primer combination Cre8/Mlys1/
Mlys2 (Cre8: 50-cccagaaatgccagattacg-30; Mlys1: 50-cttgggctgccagaa-
tttctc-30; Mlys2: 50-ttacagtcggccaggctgac-30) results in LysM-
cre amplicons of 700 and 1700 bp and in weight amplicons of
350 bp.
RNA was isolated from PMN by TRIzol (Invitrogen, Life
Technologies) and reverse-transcribed by M-MuLV reverse trans-
criptase (Roche, Rotkreuz, Switzerland). For Taqman real-time PCR,
the Applied Biosystems assays-on-demand for TGFbRII exon
boundary 3/4 (Mm01348770_m1) and TGFbRII exon boundary
6/7 (Mm00436978_m1) were used. Detection of TGFbRII mRNA
was performed by using the forward primer P1: 50-acattactctgga-
gacggtttg-30 and the reverse primer P2: 50-ggtagtgttcagcgagccatctt-30.
All real-time PCR reactions were performed and analysed on an
ABI Prism 7700 Sequence Detection SystemTM (Perkin
Elmer Applied Biosystems). The reactions for the target and
the endogenous control (18s rRNA, Applied Biosystems,
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No. 4310893) were performed in separate tubes, and the
comparative CT method was used for standardization.
Mouse meningitis model
The strain Streptococcus pneumoniae type 3, an isolate from the
CSF of a patient with pneumococcal meningitis, was used in this
study. Before use, the bacteria were subcultured on blood-agar
plates, checked for purity, inoculated into brain–heart infusion
broth (Oxoid Gmbh, Wesel, Germany), supplemented with 3%
horse serum and 1% bovine albumin (Serva, Heidelberg,
Germany) and incubated overnight at 35C. Then, the broth was
centrifuged and the sediment was washed and resuspended in
phosphate-buffered saline (PBS). The final suspension was turbi-
dometrically adjusted to a density of 0.5, thus achieving a concen-
tration of 107 colony-forming units (cfu)/ml. For inactivation,
the suspension was centrifuged again, and the pellet was incubated
in 70% ethanol for 2 h on ice, washed twice and resuspended in
PBS (to a concentration of 108 cfu/ml). The absence of viable
S. pneumoniae was proven by the lack of colony formation in
blood-agar plates.
Meningitis was induced by injection of 15 ml of a bacterial suspen-
sion containing 107 cfu/ml of S. pneumoniae type 3 into the cisterna
magna under short-term anaesthesia with halothane. Twenty-four
hours after infection, mice were evaluated clinically and treated with
the antibiotic ceftriaxone (100 mg/kg intraperitoneally). The clinical
status was evaluated before pneumococcal infection, as well as
24 and 48 h post-infection using a set of tasks, including a postural
reflex test, a beam walk test, a body proprioception test and a
spontaneous motor activity test. For postural reflex test, mice
were lifted upon fixation of the tail and symmetry in the movement
of the four limbs was examined. Score ‘0’ indicates all four limbs
extended symmetrically, 1 indicates limbs on one side extended to a
lesser degree or more slowly than those on the other side, 2 indicates
minimal movement of limbs on one or both sides and 3 indicates
lack of movement of limbs on one or both sides. The goal of the
beam walk task for a mouse was walking on wooden beams with
decreasing diameters. The score was 0, 1 or 2, if a mouse was able to
traverse a beam of 5, 9 or 13 mm in diameter, respectively. For
failure of walking along the thickest beam whose diameter was
18 mm, the score assigned was 3. Body proprioception was tested
by touching mice with a blunt stick on each side of the body. Score 0
indicates that mice reacted by turning head or were equally startled
by the stimulus on both sides, 1 indicates that mice reacted slowly to
stimulus on both sides and 2 indicates that mice did not respond to
stimulus. For evaluation of spontaneous motor activity, mice were
placed in the centre of a rectangular cage (30 cm length/20 cm
width). Score 0 indicates that mice approached at least three
walls of the cage within 60 s, 1 indicates that mice reached at
least one wall within the test interval, 2 indicates that mice only
barely moved without reaching a wall and 3 indicates that mice did
not move. In addition, if mice showed seizures, tremor, pilo-erection
or reduced vigilance, it scores 1 point for each parameter. Additional
score points were given to mice that were hypothermic (1 point =
body temperature was between 36 and 34C; 2 points = body tem-
perature was <34C) and/or had substantial loss of weight (1 point =
6–12% loss of body weight; 2 points = >12% loss of body weight).
The maximum clinical score was 19 and indicated severe disease,
whereas a score of 0 was associated with healthy uninfected mice.
Forty-eight hours after infection mice were again clinically evaluated
and anaesthetized with 100 mg/kg ketamine and 5 mg/kg xylazine.
Subsequently, a catheter was inserted into the cisterna magna to
measure ICP and to determine CSF leucocyte counts. To measure
bacterial titres, cerebella were dissected and homogenized in sterile
saline. Cerebellar homogenates were diluted serially in sterile saline,
plated on blood-agar plates and cultured for 24 h at 37C with 5%
CO2. In supplemental experiments, phag-TGFbRII
/ and
TGFbRIIflox/flox mice were evaluated clinically 24 h after infection
and followed by the determination of ICP, CSF leucocyte counts,
bacterial titres and brain albumin concentrations.
Determination of blood–brain barrier integrity
To assess BBB integrity, mouse brain homogenates were examined
for diffusion of albumin using enzyme-linked immunosorbent assay
(ELISA) (ACRIS, Bad Nauheim, Germany), an abundant serum
protein that is normally excluded from the brain by the intact
BBB, using ELISA.
Analysis of cerebral bleeding and
hydrocephalus
Mice brains were cut in a frontal plane into 10-mm-thick sections.
Beginning from the anterior parts of the lateral ventricles, 9 serial
sections were photographed with a digital camera in 0.3 mm inter-
vals throughout the ventricle system. Haemorrhagic spots were
counted and the bleeding area was measured.
Analysis of chemotaxis of PMN
Thioglycollate-elicited peritoneal exudate cells (PEC) were recovered
20 h (PMN) or 2 days (macrophages) after injection of 1 ml 3%
Brewer thioglycollate medium (Sigma, Buchs, Switzerland). The
peritoneal cavity was flushed with 10 ml of Hanks’ balanced salt
solution (HBSS) (wtihout Ca, Mg)/1% bovine serum albumin
(BSA)/15 mM Ethylenediaminetetraacetic acid (EDTA); the cells
were collected by centrifugation at 1200 r.p.m. and resuspended
to 1 · 106 cells/ml X-Vivo 15 medium (BioWhittaker, Cambrex,
Belgium)/2 mM glutamine. For fluorescence-activated cell sorter
[fetal calf serum (FACS) sorting, PEC were resuspended in FACS
buffer (2% FCS, 10 mM EDTA, in PBS)] and incubated with anti-
mouse CD16/32 (Fc-block from BD Pharmingen, Basel, Switzer-
land) for 5 min, and then stained with anti-Gr-1 fluoro-
isothiocyanate (FITC) (BD Pharmingen, Basel, Switzerland) and
anti-mouse CD11b PE (BD Pharmingen, Basel, Switzerland) for
20 min. The Gr-1high/CD11b+ PMN were sorted by an FACStar
Plus (Becton Dickinson). 7-Amino-actinomycin D (7-AAD) was
used to exclude non-viable cells in flow cytometric analysis.
To assess chemotaxis of PMN mouse CXCL2 was diluted in
X-Vivo 15 medium/2 mM glutamine at the indicated concentrations
and transferred into the lower chamber of Transwell plates
[Corning-Costar (3 mm pore size), Baar, Switzerland]. A total of
105 PMN were added to the insert in 100ml X-Vivo 15 medium/2
mM glutamine. The plates were incubated at 37C and 5% CO2 for 1
h. At the end of the incubation, the remaining cells on the upper
membrane surface were carefully removed with a cotton swab.
Migratory cells attached on the lower part of the filter were stained
with DAPI (Molecular Probes, Netherlands) at 1 mM dilution for
20 min at 37C and thereafter fixed in 4% paraformaldehyde in
PBS. Migrated PMN were counted with a square graticule (Leica
Microsystems Wetzlar GmbH, Germany), in five visual fields per
filter (three horizontal and two vertical fields crossing the middle of
the filter) at 200· magnitude.
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Flow cytometry
Brewer thioglycollate medium (1 ml), tuberculin purified protein
derivative (PPD) (50 mg/animal in PBS, Statens Serum Institut,
Denmark) or ethanol-inactivated S. pneumoniae were injected intra-
peritoneally into the right flank, and 10 h later, the mice were
challenged with 1 mg of TGF-b (1 mg/0.5 ml PBS/1% BSA) or
PBS/1% BSA into the left flank for an additional 10 h. PEC were
recovered in HBSS (wtihout Ca, Mg)/1% BSA/15 mM EDTA and
resuspended in FACS buffer. The cells were incubated with anti-
mouse CD16/32 for 5 min and stained for 20 min at 4C and washed.
Antibodies used were as follows: FITC or PE-Gr-1, anti-mouse
biotin-CD11b/APC-streptavidin, FITC-L-selectin or biotinylated-L-
selectin/APC-Cy7-streptavidin (MEL-14) (BD Pharmingen) and
PE-CXCR2 (R&D Systems, Oxon, United Kingdom). Immunofluor-
escence was detected by flow cytometry (Partec CyFlow, Mu¨nster,
Germany). Data were analysed using WinMDI 2.8 software.
Detection of cytokines
Brains of mice were screened for 62 cytokines/chemokines using a
commercially available mouse cytokine antibody array according to
the manufacturer’s instructions (RayBiotech, Atlanta, Georgia, Cat#
M0309803). Additionally, CXCL2 and TGF-b were determined
using commercially available ELISA kits (Quantikine Assay kits,
R&D Systems GmbH, Wiesbaden-Nordenstadt, FRG). Briefly,
frozen brain sections (with a total thickness of 1.8 mm) were
homogenized in lysis buffer and then centrifuged at 12 000 r.p.m.
for 15 min at 4C, and 50 ml of the supernatant was used for each
determination. Additionally, the protein concentration of the
supernatant was measured using the Nanoquant assay (Carl Roth
GmbH, Karlsruhe, FRG). Cytokine concentrations were expressed as
picograms/milligram protein.
Determination of soluble L-selectin
The peritoneum was flushed with 10 ml of HBSS (w/out Ca, Mg)/1%
BSA/15 mM EDTA and the soluble mouse L-selectin was measured
by a commercially available ELISA kit (Quantikine). The values were
obtained from three different experiments.
Production of TNFa by lipopolysaccharide
(LPS) stimulated macrophages and microglia
PEC were seeded at a density of 5 · 105 cells/well in a 24-well tissue
culture plate in DMEM/10% FCS/2 mM glutamine. Microglia were
isolated as described before (Frei et al., 1987). Briefly, each brain of
Fig. 1 Generation of mice with phagocyte-specific deletion of TGFb receptor II. (A) Breeding scheme and detection of the deletion
by RT–PCR. TGFbRIIflox/flox were crossed with Cre-bearing deleter mice in order to obtain phagocyte-specific TGFbRII deficiency.
The indicated primers were used to verify the deletion of exon 4. (B) Deletion of exon 4 in total RNA of FACS-sorted Gr-1high,
CD11b+ phag-TGFbRII/ PMN shown by RT–PCR analysis. (C) Deletion of TGFbRII exon 4 in phagocytes was determined by
Taqman real-time PCR using primers specific for the boundary of exon 3 and 4 and normalized to 18S rRNA. Shown is one out
of three representative experiments.
TGFb impairs phagocyte recruitment in meningitis Brain (2006), 129, 2404–2415 2407
newborn mice was cultured separately in a 75 cm2 tissue culture flask
for 14 days and the genotype was determined by PCR. By shaking,
the microglia were separated from astrocytes and seeded at a density
of 5 · 105 cells/well in a 24-well tissue culture plate in DMEM/10%
FCS/2 mM glutamine. After 24 h, the medium was changed to X-
Vivo 15/2 mM glutamine and macrophages or microglia were incu-
bated overnight at 37C, 5% CO2. The cells were pre-stimulated with
TGFb1 (20 ng/ml) for 2 h and then 0.01 ng LPS/ml (055:B5; Sigma)
was added for another 6 h. TNFa content in culture supernatants
was measured by a TNFa ELISA Kit (BioSource Europe, Nivelles,
Belgium).
Statistical analysis
The principal statistical test for analysing data obtained from in vivo
experiments was one-way analysis of variance and Scheffe’s test
for post hoc analysis. Subset analysis of individual clinical para-
meters was performed, including spontaneous motor activity,
beam balancing test and postural reflex test, using non-parametric
Kruskal–Wallis test and Mann–Whitney U-test with alpha correc-
tion for post hoc comparison. The Spearman-rho correlation analysis
was used to evaluate the relationship between meningitis-associated
intracranial complications (like ICP or number of haemorrhage
spots) or clinical outcome scores.
Fig. 2 TGFb induces chemotaxis and inhibits TNFa production in leucocytes of TGFbRIIflox/flox mice but not in leucocytes of
phag-TGF-bRII/ mice. (A) Migration of thioglycollate-elicited PMN of TGFbRIIflox/flox mice and phag-TGF-bRII/ mice in
response to TGFb (closed bars) or without TGFb (grey bars). Human rTGFb1 was added at various concentrations to the lower
chamber of Transwell plates; PMN were added in the upper chamber and incubated for 1 h. Migrated cells were counted in five high
power fields, and average values 6 standard deviation are depicted. (B) Macrophages were pre-stimulated for 2 h with TGFb1
(2 ng/ml) (closed bars) or without TGFb1 (grey bars) followed by a 6 h incubation period with 0.01 ng LPS/ml. (C) Microglia were
treated for 2 h with TGFb1 (2 ng/ml) (closed bars) or without TGFb1 (grey bars) followed by a 6 h incubation period with 1 ng LPS/ml.
TNFa content in the supernatant was determined by ELISA.
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Results
Generation of phagocyte-specific TGFbRII
knockout mice
For the generation of mice that lack expression of TGFbRII
on phagocytes, namely PMN and macrophages, TGFbRIIflox/
flox mice were crossed with Cre-bearing deleter mice (Fig. 1A).
This mouse line expresses Cre under control of the murine
lysozyme gene in macrophages and PMN (Clausen et al.,
1999). As shown by reverse transcription–polymerase chain
reaction (RT–PCR) analysis of total RNA, exon 4 is deleted in
FACS-sorted Gr-1high, CD11b+ PMN from phag-TGFbRII/
 mice (Fig. 1B and C). Exon 4 encodes a majority of the
TGFbRII kinase and the entire transmembrane domain. The
amount of exon 6/7 detected by real-time RT–PCR in total
RNA is similar in phag-TGFbRII/ mice and TGFbRIIflox/
flox mice (0.00255 and 0.00253, respectively). In phag-
TGFbRII/ mice TGFb-induced signalling is severely
impaired in both PMN and macrophages. TGFb induces a
strong chemotactic response of Gr-1high/CD11b+ PMN iso-
lated from the inflamed peritoneum of TGFbRIIflox/flox mice.
This contrasts with PMN from phag-TGFbRII/ mice,
which are completely resistant to TGFb-induced chemotaxis
(Fig. 2A). These data confirm the capacity of TGFb to exert a
chemotactic response in PMN (Allen et al., 1990; Welch et al.,
1990; Reibman et al., 1991). The failure of PMN from phag-
TGFbRII/ mice to migrate in response to TGFb indicates
that in thioglycollate-elicited PMN the lysozyme promoter is
activated and thereby induces a deletion of the floxed
TGFbRII gene. To test the efficiency of the lysozyme promo-
ter to induce the TGFbRII deficiency in cells of the macro-
phage lineage, the inhibition of the production of TNFa by
TGFb was measured in LPS-stimulated macrophages and
microglia. The LPS-induced secretion of TNFa was comple-
tely suppressed by TGFb in cultured thioglycollate-elicited
macrophages and to a lesser extent in microglia derived from
the CNS of TGFbRIIflox/flox mice. TGFb did not impair TNFa
production in macrophages and microglia cells obtained
from phag-TGFbRII/ mice (Fig. 2B and C). Taken collec-
tively, these results show an almost complete unresponsive-
ness of PMN, macrophages and microglia cells to the
functional effects of TGFb and provide evidence that
TGFb is chemotactic for mouse PMN.
Improved innate immunity in
S. pneumoniae- induced meningitis in
phag-TGFbRII/ mice
At 48 h after pneumococcal infection, brain concentrations of
active TGFb were significantly elevated in TGFbRIIflox/flox
mice (4.1 6 2.1 pg/mg brain protein) compared with
uninfected, PBS-injected control mice (1.1 6 0.9 pg/mg
brain protein; P = 0.020). To assess the functional role of
the endogenous production of TGFb on the host response to
bacterial infection, we used mice that lack expression of
TGFbRII on phagocytes. Infection of phag-TGFbRII/
and TGFbRIIflox/flox mice resulted in TGFb concentrations
of 1.8 6 1.0 pg/mg brain protein and 4.1 6 2.1 pg/mg brain
protein (P = 0.027), respectively. Within 24 h after inocula-
tion, all infected phag-TGFbRII/ and TGFbRIIflox/flox mice
exhibited a similar degree of disease as evidenced by a loss of
weight, hypothermia, pilo-erection, lethargy, as well as
impaired motor activity and function. One out of 20 mice
per strain died during the 24 h observation period. Moreover,
at 24 h after infection, phag-TGFbRII/ and TGFbRIIflox/flox
mice showed no differences in CSF leucocyte counts (75006
4130 cells/ml versus 10 500 6 5550 cells/ml, respectively),
bacterial titres (8.7 6 0.2 cfu/cerebellum versus 8.8 6
0.4 cfu/cerebellum, respectively), rise in ICP and brain
albumin concentrations (U. Koedel and H.W.Pfister, data
not shown). Since, without antibiotic therapy, intrathecal
challenge with 1.5 · 105 cfu S. pneumoniae causes death of
all untreatedmice within 45–48 h (U.Koedel andH.W. Pfister,
unpublished data) (Gerber et al., 2001; Chiavolini et al.,
2004), mice that were studied at a more advanced disease
stage were treated with ceftriaxone given 24 h after pneumo-
coccal inoculation. Twenty-four hours after the start of cef-
triaxone therapy, phag-TGFbRII/ mice exhibited
significantly higher CSF leucocytes than TGFbRIIflox/flox
Fig. 3 High numbers of leucocytes in cerebrospinal fluid and
low bacterial titres in the CNS of S. pneumoniae-infected
phag-TGFbRII/ mice. (A) As tested in phag-TGFbRII/
mice (n = 14) and in TGFbRIIflox/flox mice (n = 15), recruitment
of leucocytes into the CSF of S. pneumoniae-infected mice treated
with ceftriaxone is much more efficient for phag-TGFbRII/
mice than for TGFbRIIflox/flox mice (P < 0.001). (B) The higher
CSF leucocyte numbers are associated with reduced cerebellar
bacterial titres, indicating an improved clearance of bacteria in
phag-TGFbRII/ mice (P = 0.001). *Significant compared with
ceftriaxone-treated TGFbRIIflox/flox; #significant compared with
infected ceftriaxone-treated TGFbRIIflox/flox mice using one-way
analysis of variance and Scheffe’s test for post hoc analysis.
Data are expressed as means 6 standard deviation.
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mice (Fig. 3A). The enhanced CSF pleocytosis was paral-
lelled by a reduction of cerebellar bacterial titres, the latter
being 140-fold lower in phag-TGFbRII/ mice than in
TGFbRIIflox/flox controls (Fig. 3B). Thus, although TGFb
can promote prominent chemotaxis of PMN (Fig. 2A; Allen
et al., 1990; Welch et al., 1990; Reibman et al., 1991), there is
no evidence that it plays such a role in bacterial meningitis.
Absence of vasculitis and intracerebral
haemorrhages in phag-TGFbRII/ mice
Since PMN are thought to play a pivotal role in the develop-
ment of secondary brain damage in bacterial meningitis
(Tauber et al., 1988; Tuomanen et al., 1989; Weber et al.,
1997), ICP, BBB integrity and brain pathology were assessed
in both TGFbRIIflox/flox mice and phag-TGFbRII/ mice.
The macroscopic hallmarks of the disease model used here
were multifocal intracerebral haemorrhages (Fig. 4A, B and
C), which result from widespread leucocytoclastic vasculitis
of small vessels in the brain cortex and less frequently in
the white matter (Fig. 4F, G and H). Histological signs of
disseminated intravascular coagulation were seen neither in
TGFbRIIflox/flox mice nor in phag-TGFbRII/ mice. Like-
wise, infection with S. pneumoniae did not lead to bleeding
disorders and coagulopathy since coagulation parameters
(prothrombin time, activated partial thromboplastin time
and fibrinogen degradation products) remained within the
normal range. The plasma fibrinogen levels were even
increased in both mouse strains (U. Koedel and H.W.Pfister,
unpublished data). Interestingly, despite increased numbers
of PMN in the CSF, phag-TGFbRII/ mice had a 10-fold
lower number of haemorrhages in the CNS than TGFbRIIflox/
flox mice (Fig. 4D). BBB damage as reflected by increased
brain albumin concentrations was also significantly attenu-
ated in the phag-TGFbRII/ mice compared with
TGFbRIIflox/flox mice (Fig. 5B). As a consequence of the
Fig. 4 Vasculitis and brain haemorrhages are a hallmark of S. pneumoniae-infected TGFbRIIflox/flox mice but not of infected
phag-TGFbRII/ mice. Representative images of brain cryosections obtained from (A) an uninfected TGFbRIIflox/flox mouse,
(B) an infected TGFbRIIflox/flox mouse and (C) an infected phag-TGFbRII/ mouse. (D) In comparison with TGFbRIIflox/flox mice,
meningitis-induced intracerebral haemorrhages are only barely detectable in phag-TGFbRII/ mice. Compared with the uninfected
TGFbRIIflox/flox controls, both infected mouse strains showed an enlargement of the lateral ventricles (hydrocephalus). (E) The number
of intracerebral haemorrhages correlates with clinical symptoms of bacterial meningitis. (F–H) Histological analysis shows
intraparenchymal vasculitis characterized by perivascular infiltration with PMN, nuclear dusts (open arrow) and destruction of the
vessel wall with extensive haemorrhages in the parenchyma (closed arrow). Scale bar, 100 mm.
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vascular lesions, both TGFbRIIflox/flox and phag-TGFbRII/
mice showed a rise in the intracerebral pressure (ICP), which
was also significantly less pronounced in phag-TGFbRII/
mice (Fig. 5A). The extent of intracerebral haemorrhages as
well as the increase of the ICP correlated significantly with the
clinical disease score, which was in turn significantly less
affected in phag-TGFbRII/ mice compared with
TGFbRIIflox/flox mice (Figs 4E and 5C). Analysis of the indi-
vidual parameters of the clinical score revealed significantly
higher spontaneous motor activity and improved beam
balancing performance in phag-TGFbRII/ mice as com-
pared with TGFbRIIflox/flox mice; there were no significant
differences in the other parameters investigated between both
strains (Table 1). Taken collectively, the increase in the num-
bers of PMN in the CNS of phag-TGFbRII/ mice was
associated with a decreased bacterial load and prevention
of secondary brain damage, thus resulting in an amelioration
of the clinical status.
TGFb impairs the expression of
L(leucocyte)-selectin (CD62L) on
neutrophils
Next, we assessed whether differences in expression of
chemokines in phag-TGFbRII/ mice and TGFbRIIflox/flox
mice may be responsible for increased numbers of neutro-
phils in phag-TGFbRII/mice. The increase of leucocytes in
the CNS of phag-TGFbRII/ may be due to higher concen-
trations of chemokines that attract PMN, including CXCL1
(KC/GROa), CXCL2 (MIP-2) and CXCL5 (ENA/LIX). Pro-
tein arrays of mouse brain homogenates performed 48 h after
infection showed CXCL2 but not CXCL1 and CXCL5 to be
upregulated in infected TGFbRIIflox/flox mice and phag-
TGFbRII/ mice compared with uninfected control mice
(U. Koedel and H.W.Pfister, data not shown). CXCL2 as well
as CXCL1 have been identified to be responsible for chemoat-
traction of PMN in the CNF in mice with bacterial meningitis
or meningoencephalitis (Seebach et al., 1995; Diab et al.,
1999). When using ELISA techniques to quantify CXCL2 in
S. pneumoniae-infected TGFbRIIflox/flox mice and phag-
TGFbRII/ mice, comparable concentrations were observed
(7.0 6 4.3 pg/mg brain protein in infected phag-TGFbRII/
mice versus 5.8 6 3.6 pg/mg brain protein in infected
TGFbRIIflox/flox mice; the difference is not significant).
These data do not support the possibility that major differ-
ences in expression of chemokines that induce chemotaxis of
PMN may account for different numbers of PMN in the infe-
cted CSF of TGFbRIIflox/flox mice and phag-TGFbRII/mice.
Since the number of PMN that can be harvested from the
CNS of mice with meningitis is too small to allow their
characterization, PMN were studied in the peritoneal exu-
dates of mice injected with thioglycollate, an effective inducer
of neutrophil-mediated inflammation (Lewinsohn et al.,
1987). This approach is also given by the recent finding
that TGFb inhibits neutrophil migration in thioglycollate-
induced peritonitis (Gresham et al., 1991). Thioglycollate
was injected into the peritoneal cavity of TGFbRIIflox/flox
mice and phag-TGFbRII/ mice; after 10 h either TGFb
(1 mg per mouse) or control solutions were injected intra-
peritoneally and PMN were harvested from the peritoneal
exudates 10 h later. The effect of TGFb on the expression
of CXCR2, the receptor of the chemokine CXCL2 guiding
PMN chemotaxis in bacterial meningitis, was measured on
PMN by flow cytometry (Fig. 6A). TGFb altered the expres-
sion of CXCR2 neither in TGFbRIIflox/flox nor in phag-
TGFbRII/ mice (Fig. 6A). However, in TGFbRIIflox/flox
Fig. 5 Infected TGFbRIIflox/flox mice have more pronounced
secondary complications of meningitis than phag-TGFbRII/ mice.
(A) At 48 h after infection, phag-TGFbRII/ mice had significantly
lower ICP values than TGFbRIIflox/flox mice. The P-value is 0.004.
The statistical test analysis is done by one-way analysis of
variance and Scheffe’s test for post hoc analysis. (B) Vasogenic
brain oedema as assessed by determination of brain albumin
concentrations was significantly more pronounced in
ceftriaxone-treated phag-TGFbRIIflox/flox mice than in phag-
TGFbRII/ mice (P = 0.042). (C) The increase of the ICP
correlates with the clinical score of mice with bacterial meningitis.
*Significant compared with ceftriaxone-treated TGFbRIIflox/flox;
#significant compared with infected ceftriaxone-treated
TGFbRIIflox/flox mice using one-way analysis of variance and
Scheffe’s test for post hoc analysis. Data are expressed as
means 6 standard deviation.
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mice TGFb is found here to reduce the expression of
L (leucocyte)-selectin (CD62L) on PMN by 60% as calculated
from two different experiments. This effect was dependent on
TGFbRII since L-selectin was not different in PMN derived
from TGFb-treated or untreated phag-TGFbRII/ mice
(Fig. 6B). In addition, tuberculin PPD and inactivated
S. pneumoniae were used to induce PMN influx into the
peritoneum. TGFb treatment in TGFbRIIflox/flox mice
impaired L-selectin expression in both conditions. However,
no change of L-selectin expression was observed in TGFb-
treated phag-TGFbRII/ mice (Fig. 6C and D). TGFb treat-
ment did not affect the amount of shedded L-selectin mea-
sured by ELISA in the peritoneal lavage of thioglycollate-
induced mice (with TGFb 3.9 6 1.5 ng/106cells and without
TGFb 4.3 6 1.5 ng/106cells in TGFbRIIflox/flox mice; with
TGFb 5.2 6 0.8 ng/106cells and without TGFb 3.8 6 1.0
ng/106cells in phag-TGFbRII/mice). These results indicate
that TGFb interferes with the expression of L-selectin, a major
adhesion receptor that has been shown to allow leucocyte
rolling, which is a precondition for firm leucocyte adhesion
to vascular endothelium and migration of PMN in meningitis
(Lewinsohn et al., 1987; Arbones et al., 1994; Granert et al.,
1994; Tedder et al., 1995).
Discussion
We have disrupted the TGFb receptor II gene in phagocytes
and found that the absence of TGFb signalling facilitates the
recruitment of PMN and the clearance of S. pneumoniae in
the CNS of mice with meningitis. The findings in phag-
TGFbRII/ mice reported here are in agreement with pre-
vious data from our group that (i) the administration of
TGFb dampens meningeal inflammation in early pneumo-
coccal meningitis at which time endogenous levels of TGFb
in the CNS are still unaltered (Pfister et al., 1992) and that (ii)
anti-TGFb antibodies improve the antibacterial host
response in MRL/lpr mice infected with E. coli or S. aureus
(Lowrance et al., 1994). The effect of anti-TGFb antibodies
was only tested in autoimmune MRL/lpr mice, but not in
congenic MRL control mice, which, in contrast to the MRL/
lpr strain, do not express increased levels of active TGFb in
peritoneal exudates after infection with S. aureus (Lowrance
et al., 1994). However, our findings in phag-TGFbRII/
mice are in conflict with (i) the potent chemotactic response
of TGFb on PMN in vitro (Fig. 2; Reibman et al., 1991) and
(ii) the induction of inflammation when injecting TGFb into
the joints (Allen et al., 1990; Fava et al., 1991; Seebach et al.,
1995), with the observation that neutrophils from mice that
lack the TGFb-induced SMAD3 transcription factor fail to
follow a chemotactic gradient formed by TGFb in vitro or
in vivo when injecting TGFb subcutaneously (Yang et al.,
1999). Both bacterial meningitis and the inflamed perito-
neum, the disease models showing that TGFb reduces
neutrophil recruitment, comprise inflammatory responses
leading to the activation of leucocytes and endothelial
cells, expression of adhesion molecules and production ofT
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proinflammatory cytokines. This contrasts the experimental
paradigms used to show chemotactic effects of TGFb, namely
either the injection of TGFb into the non-inflamed joint or
skin or the use of TGFb in chemotactic chambers. The data
presented here provide evidence that PMN lacking TGFbRII
show a much better extravasation into the inflamed CNS in
the course of the innate immune response to S. pneumoniae in
experimental meningitis when compared with PMN with
intact TGFb receptor-mediated signalling.
To define the mechanism of impaired recruitment of
PMN to sites of inflammation, PMN were analysed for
their expression of chemokine receptors and adhesion mole-
cules. PMN harvested from the thioglycollate-induced
inflamed peritoneum of TGFb-treated TGFbRIIflox/flox and
phag-TGFbRII/  mice did not differ in their expression of
CXCR2, the receptor which is required for the recruitment of
neutrophils in experimental bacterial meningitis (Seebach
et al., 1995). However, a striking feature of TGFb-treated
PMN of TGFbRIIflox/flox mice is their profound reduction
of the expression of L-selectin, an adhesion molecule that
plays an essential role in migration of PMN to sites of
inflammation (Lewinsohn et al., 1987; Granert et al.,
1994). Inhibition of L-selectin expression by TGFb was
observed not only in thioglycollate-elicited PMN but also
when inducing PMN by intraperitoneal injection of
PPD or inactivated S. pneumoniae. Compared with control
mice L-selectin-deficient mice show a significant reduction of
PMN in thioglycollate-induced peritoneal exudates (Arbones
et al., 1994; Tedder et al., 1995). Similar results were obtained
in normal mice that have been injected with L-selectin neu-
tralizing antibodies (Watson et al., 1991). Furthermore,
extravasation of granulocytes was also diminished in joints
of L-selectin-deficient mice with experimental autoimmune
arthritis (Szanto et al., 2004). In the context of the data shown
in the present study, it is of importance that fucoidin, which
blocks the function of L-selectin, reduces the accumulation
of PMN and plasma proteins in the CSF of rabbits with
meningitis induced by intrathecal injections of S. pneumoniae
antigens (Granert et al., 1994; Angstwurm et al., 1995; Brandt
et al., 2005). On the basis of the reported functions of L-
selectin our data suggest that defective TGFb signalling in
PMN improves PMN recruitment into the CNS by increasing
L-selectin expression on PMN. However, the deletion of
Fig. 6 Stimulation of thioglycollate-elicited PMN with TGFb in vivo
reduces their expression of L-selectin. TGFbRIIflox/flox mice (left)
and phag-TGFbRII/ mice (right) were injected intraperitoneally
with thioglycollate. Ten hours later mice were treated intraper-
itoneally with either TGFb1 or PBS/BSA for an additional 10 h.
(A) Expression of CXCR2 in Gr-1+ CD11b+ PMN. Histogram
overlays show comparable levels of CXCR2 in TGFbRIIflox/flox
and phag-TGFbRII/ mice. Isotype control PE-ratIgG2a (dotted
line), thioglycollate and TGFb (grey shaded area), thioglycollate
and PBS/BSA (black line). (B) L-Selectin expression in Gr-1+
CD11b+ PMN. Histogram overlays depict a reduction of L-selectin
expression in TGFb-treated TGFbRIIflox/flox mice but not in
phag-TGFbRII/ mice. Isotype control FITC-ratIgG2a (dotted
line), thioglycollate and TGFb (grey shaded area), thioglycollate and
PBS/BSA (black line). The percentage of L-selectin+ Gr-1+ CD11b+
PMN in the different groups is as follows: TGFbRIIflox/flox mice
treated with TGFb: 10.4%; TGFbRIIflox/flox mice treated with PBS/
BSA: 31.2%. In phag-TGFbRII/ mice the respective values were
49.1 and 52.6%. (C) Gr-1+ CD11b+ PMN of animals injected
intraperitoneally with tuberculin PPD show a decrease in L-selectin
expression after TGFb treatment in TGFbRIIflox/flox mice
compared with phag-TGFbRII/ mice. Isotype control bt-
ratIgG2a/SAV-APC-Cy7 (dotted line), tuberculin PPD and TGFb
(grey shaded area), tuberculin PPD and PBS/BSA (black line). In
TGFbRIIflox/flox mice treated with TGFb: 5.1% of Gr-1+ CD11b+
PMN were L-selectin+; in TGFbRIIflox/flox mice treated with PBS/
BSA: 34.6%, respectively. In phag-TGFbRII/ mice the respective
values were 32.2 and 35.3%. (D) Intraperitoneal injection of
inactivated S. pneumoniae results in a decrease of L-selectin
expression in Gr-1+ CD11b+ PMN in TGFbRIIflox/flox mice treated
with TGFb (grey shaded area) compared with PBS-/BSA-treated
TGFbRIIflox/flox mice (black line). The percentage of L-selectin+
Gr-1+ CD11b+ PMN is as follows: TGFbRIIflox/flox mice treated
with TGFb: 31.7%; TGFbRIIflox/flox mice treated with PBS/BSA:
72.0%. In phag-TGFbRII/ mice the respective values were
67.6 and 40.0%.
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TGFbRII on phagocytes may possibly lead to L-selectin-inde-
pendent functional changes that improve both the recruit-
ment of phagocytes into the CNS and bacterial clearance. This
point needs to be clarified in future studies that should
include antibody-mediated neutralization of TGFb in
S. pneumoniae-infected wild-type mice as well as studies
on the effect of TGFb on PMN in vitro.
The data presented point to the importance of TGFb
for promoting cerebrovascular complications in bacterial
meningitis by impairing clearance of S. pneumoniae. The com-
parison of phag-TGFbRII/ mice with TGFbRIIflox/flox mice
shows that the risk of developing intracerebral vasculitis with
haemorrhages—which lead to brain oedema and thereby
cause increased ICP and cerebral hypoperfusion—increases
with a significant load of S. pneumoniae in the CNS, but not
with the presence of high numbers of neutrophils. In patients
with bacterial meningitis cerebrovascular complications are
frequent and seen in around 20% of patients (Kastenbauer
and Pfister, 2003; Weisfelt et al., 2006). In pneumococcal
meningitis, adverse outcomes with ischaemic or haemo-
rrhagic stroke are observed mainly in patients with low
CSF PMN counts and high bacterial titres (Giampaolo
et al., 1981; Scheld et al., 1982; Kastenbauer and Pfister,
2003; Weisfelt et al., 2006). This constellation is promoted
by TGFb in TGFbRIIflox/flox mice with S. pneumoniae menin-
gitis, the pathway being blocked in phag-TGFbRII/ mice.
The balance between pro- and anti-inflammatory media-
tors is critical both for preventing the innate immune
response from becoming destructive to the host and for initi-
ating repair mechanisms. TGFb has been suggested to be one
of the cytokines that counteracts the inflammatory response.
TGFb causes suppression of H2O2 release, production of
inflammatory cytokines and expression of inducible nitric
oxide synthase (see Introduction). In rats injected with
Salmonella typhosa LPS, TGFb1 arrested LPS-induced hypo-
tension and mortality (Perrella et al., 1996). It is remarkable
that even when infecting phag-TGFbRII/ mice with
S. pneumoniae, which leads to increased recruitment of
PMN to the CNS, the absence of TGFb signalling on
phagocytes does not represent a risk factor for excessive
production of leucocyte-derived inflammatory mediators
and associated multi-organ inflammation, disseminated
intravascular coagulation and organ failure. Thus, TGFb is
not a key player in the immune homeostasis of the activated
phagocyte.
In summary, our results suggest that TGFb impairs the
innate immune response by hindering the recruitment of
phagocytes to sites of infection, which results in decreased
clearance of infectious agents. Owing to this effect, TGFb
promotes inflammatory complications including cerebral
vasculitis, brain oedema and increased ICP in bacterial
meningitis. The data presented here raise the possibility
that antibodies to TGFb, TGFb neutralizing molecules such
as decorin or TGFb receptor blockers may be valuable for the
treatment of patients that have a high burden of bacteria but
only low numbers of PMN in the CSF.
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